Publications (12) Irati Hervás Corpión publications

2024

  1. Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation

    Scientific Reports, Vol. 14, Núm. 1

  2. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

    Neuro-Oncology, Vol. 26, Núm. 8, pp. 1509-1525

2023

  1. Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas

    Cells, Vol. 12, Núm. 3

  2. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 169-188

  3. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

    Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8

2022

  1. Is mouse retinal affectation by HTT cag expansion suitable for modelling the neuroinflammatory component of Huntington’s disease?

    B: Models for HD

2021

  1. Molecular pathogenesis and peripheral monitoring of adult fragile X-associated syndromes

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  2. Potential diagnostic value of the differential expression of histone h3 variants between low-and high-grade gliomas

    Cancers, Vol. 13, Núm. 21

  3. Targeting protein kinase c in glioblastoma treatment

    Biomedicines, Vol. 9, Núm. 4

2020

  1. The Epigenetics of Glioma Stem Cells: A Brief Overview

    Frontiers in Oncology, Vol. 10

2019

  1. Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Early alteration of epigenetic-related transcription in Huntington's disease mouse models

    Scientific Reports, Vol. 8, Núm. 1